Efficacy and safety of glucagon-like peptide-1 receptor agonists for diabetic cardiomyopathy: a protocol for systematic review and meta-analysis.

Tang B, Yu Y, Tang Y, Yu R, Liu X

Open source

DOI
10.1136/bmjopen-2026-121200
Published
2026 Aug 25
Container
BMJ open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2026-121200,
  title = {Efficacy and safety of glucagon-like peptide-1 receptor agonists for diabetic cardiomyopathy: a protocol for systematic review and meta-analysis.},
  author = {Tang B and Yu Y and Tang Y and Yu R and Liu X},
  year = {2026},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2026-121200},
  url = {https://doi.org/10.1136/bmjopen-2026-121200}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of glucagon-like peptide-1 receptor agonists for diabetic cardiomyopathy: a protocol for systematic review and meta-analysis.
AU  - Tang B
AU  - Yu Y
AU  - Tang Y
AU  - Yu R
AU  - Liu X
PY  - 2026
JO  - BMJ open
DO  - 10.1136/bmjopen-2026-121200
UR  - https://doi.org/10.1136/bmjopen-2026-121200
ER  - 

APA

B, T., Y, Y., Y, T., R, Y., & X, L. (2026). Efficacy and safety of glucagon-like peptide-1 receptor agonists for diabetic cardiomyopathy: a protocol for systematic review and meta-analysis.. BMJ open. https://doi.org/10.1136/bmjopen-2026-121200

Source records